| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Lite Strategy, Inc. | Director | Stock Option (Right to Buy) | 55,000 | 14 Nov 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| LITS | Lite Strategy, Inc. | 14 Nov 2025 | 1 | $0 | 4 | Director | 19 Nov 2025, 13:41 |
| MEIP | MEI Pharma, Inc. | 15 Jul 2025 | 1 | $0 | 4 | Director | 17 Jul 2025, 21:38 |
| MEIP | MEI Pharma, Inc. | 20 Sep 2023 | 1 | $0 | 4 | Director | 12 Oct 2023, 19:41 |
| MEIP | MEI Pharma, Inc. | 05 Jul 2022 | 1 | $0 | 4 | Director | 07 Jul 2022, 16:27 |
| MEIP | MEI Pharma, Inc. | 01 Jul 2021 | 1 | $0 | 4 | Director | 06 Jul 2021, 18:59 |